4.8 Article

Towards programming immune tolerance through geometric manipulation of phosphatidylserine

Journal

BIOMATERIALS
Volume 72, Issue -, Pages 1-10

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2015.08.040

Keywords

Autoimmunity; Immunoengineering; Immunomodulation; Nanoparticles; PRINT; PLGA; Phosphatidylserine; Tolerance; Transplantation

Funding

  1. NC TRACS [100K1202]
  2. NIH [U19AI109784, 8-VP1-CA174425-04, T32-AI007273-25]
  3. UCRF UNC
  4. Cancer Research Institute
  5. National Defense Science and Engineering Graduate Fellowship
  6. PhRMA Foundation
  7. University Cancer Research Fund
  8. UNC Medical Scientists Training Program [NIGMS-2-T32-GM008719]
  9. [CA1068-A-10]

Ask authors/readers for more resources

The possibility of engineering the immune system in a targeted fashion using biomaterials such as nanoparticles has made considerable headway in recent years. However, little is known as to how modulating the spatial presentation of a ligand augments downstream immune responses. In this report we show that geometric manipulation of phosphatidylserine (PS) through fabrication on rod-shaped PLGA nanoparticles robustly dampens inflammatory responses from innate immune cells while promoting T regulatory cell abundance by impeding effector T cell expansion. This response depends on the geometry of PS presentation as both PS liposomes and 1 micron cylindrical PS-PLGA particles are less potent signal inducers than 80 x 320 nm rod-shaped PS-PLGA particles for an equivalent dose of PS. We show that this immune tolerizing effect can be co-opted for therapeutic benefit in a mouse model of multiple sclerosis and an assay of organ rejection using a mixed lymphocyte reaction with primary human immune cells. These data provide evidence that geometric manipulation of a ligand via biomaterials may enable more efficient and tunable programming of cellular signaling networks for therapeutic benefit in a variety of disease states, including autoimmunity and organ rejection, and thus should be an active area of further research. (C) 2015 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available